Back to Search
Start Over
Congenital disorders of glycosylation: narration of a story through its patents.
- Source :
-
Orphanet Journal of Rare Diseases . 8/29/2023, Vol. 18 Issue 1, p1-19. 19p. - Publication Year :
- 2023
-
Abstract
- Congenital disorders of glycosylation are a group of more than 160 rare genetic defects in protein and lipid glycosylation. Since the first clinical report in 1980 of PMM2-CDG, the most common CDG worldwide, research made great strides, but nearly all of them are still missing a cure. CDG diagnosis has been at a rapid pace since the introduction of whole-exome/whole-genome sequencing as a diagnostic tool. Here, we retrace the history of CDG by analyzing all the patents associated with the topic. To this end, we explored the Espacenet database, extracted a list of patents, and then divided them into three major groups: (1) Drugs/therapeutic approaches for CDG, (2) Drug delivery tools for CDG, (3) Diagnostic tools for CDG. Despite the enormous scientific progress experienced in the last 30 years, diagnostic tools, drugs, and biomarkers are still urgently needed. [ABSTRACT FROM AUTHOR]
- Subjects :
- *CONGENITAL disorders
*GLYCOSYLATION
*PATENTS
*NARRATION
*DRUG discovery
Subjects
Details
- Language :
- English
- ISSN :
- 17501172
- Volume :
- 18
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Orphanet Journal of Rare Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 170898423
- Full Text :
- https://doi.org/10.1186/s13023-023-02852-w